AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8676421 — intervention group
Group type: EXPERIMENTAL
Intervention: VO2I/DO2I goals (Group 1)
Number of subjects: 58
Study 8676421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (after excluding those who failed VO2I/DO2I goals)
Number of subjects: 58
Study 8676421 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (after excluding the patient who died of refractory shock)
Number of subjects: 58
Study 8676421 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients maintaining mean DO2I > or = 600 during the first 24 hours
Number of subjects: 58
Study 8676421 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients not maintaining mean DO2I > or = 600 during the first 24 hours
Number of subjects: 58
Study 1804599 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g once daily + Amikacin 0.5 g
Number of subjects: 50
Study 1804599 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime 2 g twice daily + Amikacin 0.5 g b.i.d.
Number of subjects: 50
Study 1804599 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone/Amikacin
Number of subjects: 50
Study 6097173 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 g of sulbactam given in a single intramuscular dose with 1.0 g of probenecid orally
Number of subjects: 20
Study 6097173 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g of intramuscular sulbactam given twice, 4 h apart
Number of subjects: 20
Study 6097173 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric mean MIC of sulbactam for 20 pretreatment isolates of N. gonorrhoeae
Number of subjects: 20
Study 6097173 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of sulbactam
Number of subjects: 20
Study 6097173 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 20
Study 31378647 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste Exposure (TE)
Number of subjects: 219
Study 31378647 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Education (NE)
Number of subjects: 219
Study 31378647 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste Exposure + Nutrition Education (TE+NE)
Number of subjects: 219
Study 31378647 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 219
Study 29671280 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous belimumab 200 mg
Number of subjects: 356
Study 29671280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study 27008417 — intervention group
Group type: EXPERIMENTAL
Intervention: Rechargeable incentive cards (RICs)
Number of subjects: 303
Study 27008417 — intervention group
Group type: COMPARATOR
Intervention: Money orders (MOs)
Number of subjects: 303
Study 25280456 — intervention group
Group type: EXPERIMENTAL
Intervention: 5° lateral wedging
Number of subjects: 14
Study 25280456 — intervention group
Group type: COMPARATOR
Intervention: Non-wedged condition
Number of subjects: 14
Study 22277052 — intervention group
Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 271
Study 22277052 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 271
Study 20434024 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary-of-findings (SoF) table
Number of subjects: 110
Study 18525042 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia therapy (32.5 degrees C for 24 hours)
Number of subjects: 225
Study 18525042 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (37.0 degrees C)
Number of subjects: 225
Study 15661600 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Symptom Checklist for Children (TSCC)
Number of subjects: 120
Study 11795752 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete anterior discectomy (Group 1)
Number of subjects: 100
Study 11795752 — intervention group
Group type: COMPARATOR
Intervention: Partial reamed channel discectomy (Group 2)
Number of subjects: 100
Study 10436288 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized advice and assistance including self-help materials tailored for pregnancy
Number of subjects: 16
Study 10436288 — intervention group
Group type: COMPARATOR
Intervention: Intensive counseling on multiple occasions
Number of subjects: 16
Study 7677238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulose fabric face mask
Number of subjects: 9
Study 7677238 — intervention group
Group type: COMPARATOR
Intervention: Woolen scarf
Number of subjects: 9
Study 7677238 — intervention group
Group type: COMPARATOR
Intervention: No face mask
Number of subjects: 9
Study 2265493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 2265493 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 270
Study 2265493 — intervention group
Group type: EXPERIMENTAL
Intervention: M. leprae only
Number of subjects: 270
Study 2265493 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG + M. leprae
Number of subjects: 270
Study 7085368 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (cefazolin or carbenicillin, three perioperative doses)
Number of subjects: 118
Study 7085368 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic antibiotics)
Number of subjects: 118
Study 31495389 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical centre- and home-based cardiac rehabilitation program
Number of subjects: 36
Study 31495389 — intervention group
Group type: COMPARATOR
Intervention: Control group (recommendation to perform exercise at home in an uncontrolled setting)
Number of subjects: 36
Study 28130475 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual screening
Number of subjects: 0
Study 28130475 — intervention group
Group type: COMPARATOR
Intervention: Personalized screening
Number of subjects: 0
Study 26360974 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology Tape (KT)
Number of subjects: 30
Study 26360974 — intervention group
Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 30
Study 23394404 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon (Sequent please; B. Braun) followed by bare metal stent (Coroflex Blue; B. Braun)
Number of subjects: 180
Study 23394404 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (Resolute Integrity; Boston Scientific)
Number of subjects: 180
Study 21247998 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (4 μg/kg twice daily)
Number of subjects: 283
Study 21247998 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 283
Study 19959692 — intervention group
Group type: EXPERIMENTAL
Intervention: Expired carbon monoxide (CO)
Number of subjects: 700
Study 19959692 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma cotinine (COT)
Number of subjects: 700
Study 19959692 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2A6 activity
Number of subjects: 700
Study 17179442 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 34
Study 17179442 — intervention group
Group type: COMPARATOR
Intervention: Submotor electrical stimulation (ES)
Number of subjects: 34
Study 17179442 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 34
Study 15252886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycloid psychosis
Number of subjects: 77
Study 15252886 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 77
Study 15252886 — intervention group
Group type: COMPARATOR
Intervention: Controls (48 individuals)
Number of subjects: 77
Study 11593458 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape preparation before hip replacement surgery
Number of subjects: 100
Study 11593458 — intervention group
Group type: COMPARATOR
Intervention: Control group (no videotape preparation)
Number of subjects: 100
Study 11593458 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape preparation
Number of subjects: 100
Study 9512197 — intervention group
Group type: EXPERIMENTAL
Intervention: Aptamil-LCP
Number of subjects: 61
Study 9512197 — intervention group
Group type: COMPARATOR
Intervention: Standard Aptamil
Number of subjects: 61
Study 9512197 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 61
Study 8063242 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold knife conization
Number of subjects: 110
Study 8063242 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser conization
Number of subjects: 110
Study 8063242 — intervention group
Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 110
Study 8063242 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 110
Study 2657467 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine 60 mg orally
Number of subjects: 15
Study 2657467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 125133 — intervention group
Group type: EXPERIMENTAL
Intervention: Methandienone 10 mg/day
Number of subjects: 13
Study 125133 — intervention group
Group type: EXPERIMENTAL
Intervention: Methandienone 25 mg/day
Number of subjects: 13
Study 125133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 31912305 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal hydrokinesiotherapy
Number of subjects: 11
Study 31710011 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil (SO)
Number of subjects: 75
Study 31710011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated sesame oil (OSO)
Number of subjects: 75
Study 31710011 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (CHX)
Number of subjects: 75
Study 28286189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried aqueous spearmint extract (600 mg/day) for 90 days
Number of subjects: 0
Study 28286189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried aqueous spearmint extract (900 mg/day) for 90 days
Number of subjects: 0
Study 28286189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26420770 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised intervention
Number of subjects: 43
Study 26420770 — intervention group
Group type: COMPARATOR
Intervention: Control group (no extra care)
Number of subjects: 43
Study 23713310 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular point group A (magnetic beads on specific auricular points)
Number of subjects: 120
Study 23713310 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular point group B (magnetic beads on preauricular and retroauricular points)
Number of subjects: 120
Study 23713310 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (plasters on corresponding auricular points)
Number of subjects: 120
Study 21899741 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g cinnamon
Number of subjects: 9
Study 21899741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 17538539 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 g/day of plant sterols (PS) for 3 weeks
Number of subjects: 0
Study 17538539 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g/day of plant sterols (PS) for 3 weeks
Number of subjects: 0
Study 17538539 — intervention group
Group type: EXPERIMENTAL
Intervention: Tall oil (TO) containing 78% sitosterol
Number of subjects: 0
Study 17538539 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil (BO) containing 27% campesterol
Number of subjects: 0
Study 17538539 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols (PS) withdrawal
Number of subjects: 0
Study 17511685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 17511685 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid (methylprednisolon)
Number of subjects: 110
Study 15076013 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (200-800 mg/day)
Number of subjects: 0
Study 15076013 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 0
Study 15076013 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 0
Study 15076013 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 0
Study 11688766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (NI) 30-60 mg once a day
Number of subjects: 54
Study 11688766 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (AM) 5-10 mg once a day
Number of subjects: 54
Study 9507416 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic electrical stimulation of the posteroventral internal pallidum
Number of subjects: 0
Study 9507416 — intervention group
Group type: COMPARATOR
Intervention: Stimulation turned off
Number of subjects: 0
Study 7837683 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (omeprazole 20mg once daily)
Number of subjects: 11
Study 7837683 — intervention group
Group type: COMPARATOR
Intervention: H2-blocker (famotidine 20mg twice daily)
Number of subjects: 11
Study 3045781 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (40 mg/kg/day for 10 days)
Number of subjects: 100
Study 3045781 — intervention group
Group type: COMPARATOR
Intervention: Dicloxacillin (25 mg/kg/day for 10 days)
Number of subjects: 100
Study 29131285 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised tomato extract (STE)
Number of subjects: 82
Study 29131285 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 82
Study 27650864 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 8000
Study 27650864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8000
Study 24912561 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance rehabilitation aimed at improving motor and sensory strategies
Number of subjects: 53
Study 24912561 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation treatment which did not include training of sensory strategies
Number of subjects: 53
Study 22809962 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelargonium sidoides
Number of subjects: 28
Study 22809962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 20509752 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg b.i.d. + Amoxicillin 1000 mg + Clarithromycin 500 mg for 1 week followed by placebo for 3 weeks
Number of subjects: 401
Study 20509752 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg b.i.d. + Placebo antibiotics for 1 week followed by Esomeprazole 20 mg o.d. for 3 weeks
Number of subjects: 401
Study 20509752 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg o.d. after initial treatment
Number of subjects: 401
Study 20509752 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole alone
Number of subjects: 401
Study 18793576 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg exenatide
Number of subjects: 24
Study 18793576 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg exenatide
Number of subjects: 24
Study 16035144 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 5 mg
Number of subjects: 32
Study 16035144 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 15 mg
Number of subjects: 32
Study 16035144 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 45 mg
Number of subjects: 32
Study 16035144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 12236071 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release sparfloxacin chip (SRS chip)
Number of subjects: 0
Study 12236071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10037246 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 (1 microg/kg/h)
Number of subjects: 86
Study 10037246 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH + GHRP-2
Number of subjects: 86
Study 10037246 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH + GHRH + GHRP-2
Number of subjects: 86
Study 10037246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 10037246 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1 microg/kg/h)
Number of subjects: 86
Study 10037246 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH (1 microg/kg/h)
Number of subjects: 86
Study 7669991 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine 75 mg
Number of subjects: 8
Study 7669991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7669991 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine 25 mg
Number of subjects: 8
Study 7669991 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline examination (responders vs non-responders)
Number of subjects: 8
Study 7669991 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal volume
Number of subjects: 8
Study 1823750 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide, 25 mg/day
Number of subjects: 15
Study 1823750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 7193918 — intervention group
Group type: COMPARATOR
Intervention: i.v. DDAVP (0.1‐0.4 μg/Kg)
Number of subjects: 17
Study 7193918 — intervention group
Group type: COMPARATOR
Intervention: i.n. DDAVP (1‐4 μg/Kg)
Number of subjects: 17
Study 7193918 — intervention group
Group type: COMPARATOR
Intervention: i.v. DDAVP (0.4 μg/Kg) single dose
Number of subjects: 17
Study 7193918 — intervention group
Group type: COMPARATOR
Intervention: i.v. DDAVP (0.4 μg/Kg) repeated doses
Number of subjects: 17
Study 31688513 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) training at 30% maximal voluntary contraction, 3 days/week for 6 weeks
Number of subjects: 11
Study 31688513 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 11
Study 28684276 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (100µg/50µl) administered into ST36 or ST37 acupoint
Number of subjects: 0
Study 28684276 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin administered into ST36 acupoint
Number of subjects: 0
Study 28684276 — intervention group
Group type: EXPERIMENTAL
Intervention: 43°C heating-needle stimulation applied to ST36 acupoint for 30-45 minutes
Number of subjects: 0
Study 28684276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive treatment of contralateral ST36 acupoint with 43°C heating-needle stimulation
Number of subjects: 0
Study 28684276 — intervention group
Group type: COMPARATOR
Intervention: Non-acupoint area treatment
Number of subjects: 0
Study 25976567 — intervention group
Group type: EXPERIMENTAL
Intervention: S-line blood-liquid warmer with Mediset infusion set
Number of subjects: 20
Study 25976567 — intervention group
Group type: COMPARATOR
Intervention: Intrafix Primeline Confortset (IPC)
Number of subjects: 20
Study 23372363 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 102
Study 23372363 — intervention group
Group type: COMPARATOR
Intervention: Three-port laparoscopic cholecystectomy (TPLC)
Number of subjects: 102
Study 21330044 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth-to-mouth ventilation (MMV)
Number of subjects: 60
Study 21330044 — intervention group
Group type: COMPARATOR
Intervention: Mouth-to-pocket mask ventilation (MPV)
Number of subjects: 60
Study 21330044 — intervention group
Group type: COMPARATOR
Intervention: Bag-valve-mask ventilation (BMV)
Number of subjects: 60
Study 18931095 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg/day
Number of subjects: 1091
Study 18931095 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.2 mg/day
Number of subjects: 1091
Study 18931095 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 0.6 mg/day
Number of subjects: 1091
Study 18931095 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride 4 mg/day
Number of subjects: 1091
Study 18931095 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (all doses)
Number of subjects: 1091
Study 18931095 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 1091
Study 18931095 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 1091
Study 18931095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1091
Study 17450978 — intervention group
Group type: EXPERIMENTAL
Intervention: individual‐group‐individual technique
Number of subjects: 149
Study 17450978 — intervention group
Group type: EXPERIMENTAL
Intervention: nominal group technique
Number of subjects: 149
Study 17450978 — intervention group
Group type: COMPARATOR
Intervention: nonstructured interactive groups (Control)
Number of subjects: 149
Study 15059710 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (400 mg/d)
Number of subjects: 44
Study 15059710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 12008788 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleconaril 400 mg three-times daily for 7 days
Number of subjects: 587
Study 12008788 — intervention group
Group type: COMPARATOR
Intervention: Pleconaril 400 mg three-times daily
Number of subjects: 587
Study 9513910 — intervention group
Group type: EXPERIMENTAL
Intervention: F80B dialyzer (high-flux polysulfone)
Number of subjects: 6
Study 9513910 — intervention group
Group type: EXPERIMENTAL
Intervention: T220L dialyzer (high-efficiency cellulose)
Number of subjects: 6
Study 7652038 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental (stress) condition
Number of subjects: 33
Study 7652038 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 33
Study 2569485 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg acetaminophen plus 60 mg phenyltoloxamine citrate
Number of subjects: 200
Study 2569485 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg acetaminophen alone
Number of subjects: 200
Study 2569485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 356078 — intervention group
Group type: EXPERIMENTAL
Intervention: diastolic blood pressure feedback, electromyographic feedback, and verbal relaxation
Number of subjects: 22
Study 356078 — intervention group
Group type: COMPARATOR
Intervention: sham blood pressure feedback
Number of subjects: 22
Study 356078 — intervention group
Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 22
Study 31340845 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat marginal endocrown
Number of subjects: 200